Showing results (621-630 of 1,025) with videos related to

Sort By:
Pageof 103
Cancer|August 26, 2010
Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experienceChristos Vaklavas, Apostolia-Maria Tsimberidou, Sijin Wen, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|January 9, 1999
Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreasD B Evans, P W Pisters, J E Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of VaterMichael J Overman, Gauri R Varadhachary, Scott Kopetz, et al.
Environmental Science & Technology|February 6, 2009
Hydroxamate siderophores: occurrence and importance in the Atlantic OceanEdward Mawji, Martha Gledhill, James A Milton, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2018
VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristicsJinsy A Andrews, Merit E Cudkowicz, Orla Hardiman, et al.
Pediatric Blood & Cancer|October 24, 2009
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumoursHilko Ardon, Steven De Vleeschouwer, Frank Van Calenbergh, et al.
The Science of the Total Environment|August 10, 2016
How we can make ecotoxicology more valuable to environmental protectionM L Hanson, B A Wolff, J W Green, et al.
Annals of Internal Medicine|December 22, 2010
Reconsidering the approach to prevention recommendations for older adultsRosanne M Leipzig, Evelyn P Whitlock, Tracy A Wolff, et al.
Cancer Research|March 17, 2006
Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survivalDonghui Li, Hui Liu, Li Jiao, et al.
Molecular Pharmaceutics|June 15, 2013
Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+Frank Thévenod, Giuliano Ciarimboli, Marcus Leistner, et al.
Pageof 103